Clinical Trials Logo

Rectal Tumor clinical trials

View clinical trials related to Rectal Tumor.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04013347 Completed - Surgery Clinical Trials

Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery

Start date: January 1, 2005
Phase:
Study type: Observational

Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal tumours. Ideal time interval between the end of NRCT and surgery is still debated; a 6-8 weeks time interval is considered optimal, but shorter or longer intervals have been associated with better oncological outcomes. Moreover, there is a lack of data about clinical postoperative outcomes and different time intervals after the end of NRCT. Here, effect that different time intervals have on postoperative complications with particular regard to the anastomotic dehiscence have been evaluated. Methods One hundred-sixty-seven patients underwent surgery after long-course NRCT. Three different time intervals were considered: (0-42; 43-56; >57 days).